These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31505389)

  • 21. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
    Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
    Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo intragenic deletion of the autism susceptibility candidate 2 (AUTS2) gene in a patient with developmental delay: a case report and literature review.
    Jolley A; Corbett M; McGregor L; Waters W; Brown S; Nicholl J; Yu S
    Am J Med Genet A; 2013 Jun; 161A(6):1508-12. PubMed ID: 23650183
    [No Abstract]   [Full Text] [Related]  

  • 23. Establishment of a human induced pluripotent stem cell line (SDQLCHi004-A) from a patient with nemaline myopathy-4 disease carrying heterozygous mutation in TPM2 gene.
    Ma Y; Zhang H; Yang X; Li Y; Guan J; Lv Y; Li H; Liu Y; Gai Z
    Stem Cell Res; 2019 Oct; 40():101559. PubMed ID: 31526942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
    Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
    Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of nine induced pluripotent stem cell lines from six young children with autism spectrum disorder and three matched control subjects from the Qatari population.
    Ltaief SM; Elsayed AK; Al-Shammari AR
    Stem Cell Res; 2024 Sep; 79():103470. PubMed ID: 38896970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene.
    Li Y; Zhang H; Yan B; Ma Y; Yang X; Guan J; Lv Y; Gao M; Ma J; Gai Z; Liu Y
    Stem Cell Res; 2019 Oct; 40():101579. PubMed ID: 31610500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene.
    Zhang H; Ma Y; Yan B; Yang X; Li Y; Guan J; Dong R; Liu Y; Gai Z
    Stem Cell Res; 2019 Oct; 40():101565. PubMed ID: 31522012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an integration-free iPSC line, ICCSICi005-A, derived from a Parkinson's disease patient carrying the L444P mutation in the GBA1 gene.
    Rodríguez-Traver E; Rodríguez C; Díaz-Guerra E; Arenas F; Araúzo-Bravo M; Orera M; Kulisevsky J; Moratalla R; Vicario C
    Stem Cell Res; 2019 Oct; 40():101578. PubMed ID: 31539859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exonic deletions of AUTS2 in Chinese patients with developmental delay and intellectual disability.
    Fan Y; Qiu W; Wang L; Gu X; Yu Y
    Am J Med Genet A; 2016 Feb; 170A(2):515-522. PubMed ID: 26545289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of an induced pluripotent stem cell line SJTUXHi001-A from an autism spectrum disorder patient carrying a heterozygous mutation in HDAC8 (p.P359S).
    Chen Z; Lv H; Yu J; Fang S; Li F
    Stem Cell Res; 2022 May; 61():102756. PubMed ID: 35358829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMIP haploinsufficiency in two patients with autism spectrum disorder and co-occurring gastrointestinal issues.
    Luo M; Fan J; Wenger TL; Harr MH; Racobaldo M; Mulchandani S; Dubbs H; Zackai EH; Spinner NB; Conlin LK
    Am J Med Genet A; 2017 Aug; 173(8):2101-2107. PubMed ID: 28504353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
    Toustrup LB; Zhou Y; Kvistgaard H; Gregersen N; Rittig S; Aagaard L; Corydon TJ; Luo Y; Christensen JH
    Stem Cell Res; 2017 Mar; 19():37-42. PubMed ID: 28413003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene.
    Domingo-Prim J; Riera M; Abad-Morales V; Ruiz-Nogales S; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Oct; 40():101570. PubMed ID: 31518904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A).
    Jelinkova S; Markova L; Pesl M; Valáškova I; Makaturová E; Jurikova L; Vondracek P; Lacampagne A; Dvorak P; Meli AC; Rotrekl V
    Stem Cell Res; 2019 Oct; 40():101562. PubMed ID: 31526943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant calcium channel splicing drives defects in cortical differentiation in Timothy syndrome.
    Panagiotakos G; Haveles C; Arjun A; Petrova R; Rana A; Portmann T; Paşca SP; Palmer TD; Dolmetsch RE
    Elife; 2019 Dec; 8():. PubMed ID: 31868578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():70-72. PubMed ID: 28395810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
    Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
    Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
    Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
    Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1.
    Zhang H; Ma Y; Song F; Yang X; Li Y; Guan J; Lv Y; Gao M; Ma J; Liu Y; Gai Z
    Stem Cell Res; 2019 Aug; 39():101505. PubMed ID: 31415973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.